Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health

NCT06318390 is registered in ClinicalTrials.gov with The University of Texas at Arlington as lead sponsor.

NCT NCT06318390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06318390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health
Lead sponsor
The University of Texas at Arlington
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2023
Completion date
May 31, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cognitive decline, diet, healthy, hypertension